Quarterly Results, Broker Conferences, Special IR Events FY2019 (April 2019-March 2020)

R&D Day and Plasma-Derived Therapies Day in Tokyo (11:00am-5:00pm JST on November 21, 2019)

Webcast

Plasma-Derived Therapies

  • Plasma-Derived Therapies Overview 
    Julie Kim, President, Plasma-Derived Therapies Business Unit
  • Plasma-Derived Therapies R&D 
    Christopher Morabito, Head, R&D, Plasma-Derived Therapies
    Click to Download 

R&D Day

All slides
Click to Download 

  • Takeda: A Global Values-Based, R&D-Driven Biopharmaceutical Leader 
    Christophe Weber, President & CEO
    Click to Download 
  • Translating Science into Highly Innovative, Life-changing Medicines 
    Andy Plump, President, R&D
    Click to Download 
  • Oncology and Cell Therapies with Spotlight on CAR-NK 
    Chris Arendt, Head, Oncology Drug Discovery Unit
    Click to Download 
  • Spotlight on Oncology Opportunities TAK-788 
    Rachael Brake, Global Program Leader, Oncology
    Click to Download 
  • Spotlight on Oncology Opportunities Pevonedistat 
    Phil Rowlands, Head, Oncology Therapeutic Area Unit
    Click to Download 
  • Rare Diseases & Gene Therapy 
    Dan Curran, Head, Rare Disease Therapeutic Area Unit
    Click to Download 
  • Spotlight on Orexin2R agonists 
    Deborah Hartman, Global Program Leader, Neuroscience
    Click to Download 
  • Therapeutic Area Focus in GI with Spotlight on Celiac Disease 
    Asit Parikh, Head, GI Therapeutic Area Unit
    Click to Download 

Takeda R&D Pipeline Narrative
Click to Download

Plasma-Derived Therapies Day in Covington, Georgia (11:15am-3:45pm EST on November 15, 2019)

Webcast

All slides
Click to Download 

  • Plasma-Derived Therapies Overview 
    Julie Kim, President, Plasma-Derived Therapies Business Unit

  • Plasma-Derived Therapies R&D 
    Christopher Morabito, Head, R&D, Plasma-Derived Therapies

  • Covington Site Introduction 
    Carlos Soto, Covington Site Head

R&D Day in New York (12:30pm-4:00pm EST on November 14, 2019)

Webcast

All slides
Click to Download

Welcome and Opening Remarks
Sheelagh Cawley-Knopf, Head, R&D Global Portfolio Strategy

  • Takeda: A Global Values-Based, R&D-Driven Biopharmaceutical Leader
    Christophe Weber, President & CEO
    Click to Download 
  • Translating Science into Highly Innovative, Life-changing Medicines
    Andy Plump, President, R&D
    Click to Download 
  • Oncology and Cell Therapies with Spotlight on CAR-NK
    Chris Arendt, Head, Oncology Drug Discovery Unit
    Click to Download
  • Spotlight on Oncology Opportunities TAK-788
    Rachael Brake, Global Program Leader, Oncology
    Click to Download 
  • Spotlight on Oncology Opportunities Pevonedistat
    Phil Rowlands, Head, Oncology Therapeutic Area Unit
    Click to Download 
  • Rare Diseases & Gene Therapy
    Dan Curran, Head, Rare Disease Therapeutic Area Unit
    Click to Download
  • Spotlight on Orexin2R agonists
    Deborah Hartman, Global Program Leader, Neuroscience
    Click to Download 
  • Therapeutic Area Focus in GI with Spotlight on Celiac Disease
    Asit Parikh, Head, GI Therapeutic Area Unit
    Click to Download

Takeda R&D Pipeline Narrative
Click to Download

FY2019 Q2Results (released on October 31, 2019)

Consolidated Financial Statements submitted to TSE (Tokyo Stock Exchange)
(Without Independent Auditors report)
Click to download

Press Release

Data Book
Click to download

Earnings Release Presentation

For Investors and Analysts

A Competitive, Values-based, R&D-driven, Global Biopharmaceutical Leader
Christophe Weber, President & Chief Executive Officer
Andrew Plump, President, Research & Development
Costa Saroukos, Chief Financial Officer, and others
Click to download

For Media

A Competitive, Values-based, R&D-driven, Global Biopharmaceutical Leader
Christophe Weber, President & Chief Executive Officer, and others
Click to download


Supplementary materials for the financial statements
Underlying Core Reconciliation
Click to download

On-demand Webcast (Earnings meeting: For Investors & Analysts: 5:45pm-7:00pm JST)

On-demand Audio(Conference call 9:00pm-9:45pm JST)

IR meeting with analysts and investors with Julie Kim, President of Takeda's Plasma-Derived Therapies Business Unit (Held on October 10, 2019)

Morgan Stanley Healthcare Conference (Held on September 10, 2019 ET)

Audio
*Link to conference website

FY2019 Q1 Results (released on July 31, 2019)

Partial Correction of Financial Statements submitted to TSE (Tokyo Stock Exchange)
Click to download


Consolidated Financial Statements submitted to TSE (Tokyo Stock Exchange)

(Without Independent Auditor’s report)
Click to download


Press Release
 

Data Book
Click to download


Earnings Release Presentation

CONSOLIDATED FINANCIAL RESULTS FOR FY2019 Q1
Costa Saroukos, Chief Financial Officer
Click to download


Supplementary materials for the financial statements

Underlying Core Reconciliation
Click to download

Financial FAQs regarding FY2019 Q1 earnings
Click to download


Audio Conference Call

IR Seminar “Plasma-Derived Therapies Business” (Held on July 12, 2019)

Quarterly Results, Broker Conferences, Special IR Events Archive